Skip to main content
Joseph U. Kim

Joseph U. Kim, PhD

Languages spoken: English, Korean

Academic Information

Departments Adjunct - Psychiatry

Divisions: Adult Psychiatry

Research Interests

  • Transcranial Magnetic Stimulation
  • Stress and Emotion Regulatory Mechanisms in the Human Brain

Joseph Kim, PhD, is a neuropsychologist and Assistant Professor in the Department of Psychiatry at the University of Utah School of Medicine. As a clinical psychologist, his interests include neuropsychological evaluation of memory and thinking problems in adulthood as well as providing time-limited psychotherapy to patients to address executive impairments, such as difficulty in organizing and planning.

Dr. Kim received his BA from the University of Wisconsin - Madison and his PhD from Vanderbilt University. He completed his doctoral internship training in Clinical Psychology - neuropsychology track at the Duke University Medical Center. Following his internship, Dr. Kim was appointed a postdoctoral fellow at the University of Utah School of Medicine, where he engaged in research and clinical care in the area of neuropsychology and clinical neuroscience. Upon completing his fellowship, Dr. Kim joined the faculty of the Department of Psychiatry and is actively involved in neuroimaging (fMRI) and neuromodulation (TMS) research in the area of emotion regulation across the life span and psychiatric disorders.

Education History

Postdoctoral Fellowship University of Utah School of Medicine
Postdoctoral Fellow
Duke University Medical Center
Intern
Doctoral Training Vanderbilt University
PhD
Vanderbilt University
MA
Undergraduate University of Wisconsin–Madison
BA

Selected Publications

Journal Article

  1. Dotson VM, McClintock SM, Verhaeghen P, Kim JU, Draheim AA, Syzmkowicz SM, Gradone AM, Bogoian HR, Wit L (2020). Depression and Cognitive Control across the Lifespan: a Systematic Review and Meta-Analysis. Neuropsychol Rev, 30, 461-476. (Read full article)
  2. Weisenbach SL, Kim JU, Hammers D, Konopacki K, Koppelmans V (2019). Linking Late Life Depression and Alzheimer’s Disease: Mechanisms and Resilience. Curr Behav Neurosci Rep, 6, 103-112.
  3. Kim JU, Weisenbach SL, Zald DH (2018). Ventral prefrontal cortex and emotion regulation in aging: A case for utilizing transcranial magnetic stimulation. Int J Geriatr Psychiatry, 34(2), 215-222. (Read full article)
  4. McClintock SM, Kallioniemi E, Martin DM, Kim JU, Weisenbach SL, Abbott CC (2019). A Critical Review and Synthesis of Clinical and Neurocognitive Effects of Noninvasive Neuromodulation Antidepressant Therapies. Focus (Am Psychiatr Publ), 17(1), 18-29. (Read full article)
  5. Dotson VM, Szymkowicz SM, Kim JU, McClintock SM (2018). Cognitive functioning in late-life depression: A critical review of sociodemographic, neurobiological, and treatment correlates. Curr Behav Neurosci Rep, 5(4), 310-318.
  6. Morimoto SS, Manning KJ, Kim JU, Cote SE (2018). Non-Pharmacological Cognitive Remediation Strategies for Treatment of Depression and Cognitive Impairment. Curr Behav Neurosci Rep.

Book Chapter

  1. Kozbelt A, Kaufman SB, Walder DJ, Ospina LH, Kim JU (2014). The evolutionary genetics of the creativity-psychosis connection. In Kaufman JC (Ed.), Creativity and Mental Illness. Cambridge, UK: Cambridge University Press.
  2. Kim JJ, Kim JU (2010). Virtual reality-based assessment of social skills and its application to mental illnesses. In Kim JJ (Ed.), Virtual Reality. InTech.

Editorial

  1. Weisenbach SL, Kim J (2017). Potential Treatment Targets for Modulation of Affective Reactivity in Mild Cognitive Impairment. Am J Geriatr Psychiatry, 25(11), 1234-1235. (Read full article)

Abstract

  1. Kim JU, Koppelmans V, Tasevac B, Durnford K, Germain J, Langenecker S, Weisenbach SL (2019). Why so Serious? Ability to Accurately Identify Happy Faces is Associated With Individual Differences in Lateral-Orbitofrontal Cortex Volume in Older Men. [Abstract]. 85(10), S130.
  2. Kim JU, Weisenbach SL, Avery E, Heffernan J, Pecina M, Zubieta JK, Mickey B (2017). Striatal Dopamine D2/D3 Receptor Availability Predicts Episodic Verbal Memory and Executive Function in Medication-Free Major Depressive Disorder Patients [Abstract]. 81(10), S331.